(Press-News.org) Baltimore, Md., June 29, 2015 - As the South Korean epidemic of Middle East Respiratory Syndrome (MERS) continues unabated, researchers have raced to find treatments for the deadly virus, which has killed more than 400 people since it was first discovered three years ago in Saudi Arabia.
Now, scientists at the University of Maryland School of Medicine and Regeneron Pharmaceuticals, Inc., have discovered and validated two therapeutics that show early promise in preventing and treating the disease, which can cause severe respiratory symptoms, and has a death rate of 40 percent. These therapeutics are the first to succeed in protecting and treating animal models of the MERS virus. The study appears today in the latest issue of the journal Proceedings of the National Academy of Sciences (PNAS).
"While early, this is very exciting, and has real potential to help MERS patients," says a lead researcher on the study, Matthew B. Frieman, PhD, an assistant professor of microbiology and immunology at the University of Maryland School of Medicine (UM SOM). "We hope that clinical study will progress on these two antibodies to see whether they can eventually be used to help humans infected with the virus."
The two antibodies, REGN3051 and REGN3048, showed an ability to neutralize the virus. This research, done in collaboration with Regeneron, a biopharmaceutical company based in Tarrytown, New York, used several of the company's proprietary technologies to search for and validate effective antibodies targeting the virus.
MERS was first discovered in 2012 in Saudi Arabia. It appears that the disease spread to humans from camels, who may themselves been infected by bats. Research has shown that it is similar to Severe acute respiratory syndrome (SARS); both are caused by Coronaviruses, both cause respiratory problems, and both are often fatal.
The paper also announced the development a novel strain of mice, which will help scientists understand the disease and look for treatments. This work relied on Regeneron's VelociGene technology to create partially humanized mice that can be infected with MERS.
"Mice are typically not susceptible to MERS," said Prof. Frieman, who is an expert on both MERS and SARS, as well as other emerging viruses. "This new mouse model will significantly boost our ability to study potential treatments and help scientists to understand how the virus causes disease in people."
The South Korean outbreak began last month when a traveler returned from Saudi Arabia, and infected many people before officials realized he had the disease. So far, around 180 people have been infected in South Korea, and nearly 30 have died.
"Prof. Frieman's work provides the first glimmer of hope that we can treat and cure this threatening virus," said Dean E. Albert Reece, MD, PhD, MBA, who is also the vice president for Medical Affairs, University of Maryland, and the John Z. and Akiko K. Bowers Distinguished Professor and Dean of the School of Medicine. "I know that they will continue to work hard to see whether these compounds can take the next steps to clinical trials."
INFORMATION:
About the University of Maryland School of Medicine
The University of Maryland School of Medicine was chartered in 1807 and is the first public medical school in the United States and continues today as an innovative leader in accelerating innovation and discovery in medicine. The School of Medicine is the founding school of the University of Maryland and is an integral part of the 11-campus University System of Maryland. Located on the University of Maryland's Baltimore campus, the School of Medicine works closely with the University of Maryland Medical Center and Medical System to provide a research-intensive, academic and clinically based education. With 43 academic departments, centers and institutes and a faculty of more than 3,000 physicians and research scientists plus more than $400 million in extramural funding, the School is regarded as one of the leading biomedical research institutions in the U.S. with top-tier faculty and programs in cancer, brain science, surgery and transplantation, trauma and emergency medicine, vaccine development and human genomics, among other centers of excellence. The School is not only concerned with the health of the citizens of Maryland and the nation, but also has a global presence, with research and treatment facilities in more than 35 countries around the world.
medschool.umaryland.edu/
Alexandria, Va., USA - Today, the International and American Associations for Dental Research (IADR/AADR) published a case report on the first application of a 3D printed scaffold for periodontal tissue engineering in a human patient, along with a review of 3D printing for oral and craniofacial tissue engineering. These papers are published in the latest clinical supplement to the Journal of Dental Research, which encompasses all areas of clinical research in the dental, oral and craniofacial sciences, and brings emerging contributions in discovery and translational science ...
The goal for many cancer patients is to reach the five-year, disease-free mark, but new research from UR Medicine's Wilmot Cancer Institute suggests that two years might be a more practical survival goal for people with follicular lymphoma.
The difference underscores the fact that about 20 percent of follicular lymphoma patients consistently experience their disease coming back within two years of being treated with the latest therapies--despite the fact that most follicular lymphoma patients can expect to live 20 years.
People who relapse early may have a disease with ...
NEW YORK (29 June 2015) -- There has been much recent discussion in the press of the plight of the so-called "sandwich generation," that is, adults who are responsible for the care of children as well as aging parents. The need for simultaneous childcare and eldercare is a reality that can limit families'--particularly women's--opportunities for paying work.
A new study by social scientists Emilio Zagheni and Denys Dukhovnov for the first time drills down into US statistics about who is providing this care, and who is receiving it. The study found that in 2012, adults ...
WASHINGTON (June 29, 2015) -- As Liberia rebuilds a health care system decimated by the 2014 Ebola outbreak, understanding precisely how far citizens live from health facilities and its impact on seeking care can help shape new strategies to improve health care delivery and reduce geographic disparities.
A new examination of remoteness as a barrier to health care, published online today in the Journal of Global Health, notes that most surveys and policy documents categorize families as living either in an urban or rural setting, and this dichotomy can mask disparities ...
When it comes to the art of persuasion, you can attract more followers if you turn conventional wisdom on its head and stress what you like, not what you do.
A new study, to be published in an upcoming issue of the Journal of Personality and Social Psychology, finds that people are more likely to conform to others' preferences than conform to others' actions. In other words, people want to like what others like, but they want to have or do what others don't have or don't do.
In the study, "Words Speak Louder: Conforming to Preferences More Than Actions," by University ...
DURHAM, N.C. - Researchers at Duke University School of Medicine and Brigham and Women's Hospital, Harvard Medical School have identified a mechanism that explains why some mutations can be disease-causing in one genome but benign in another.
In a study appearing June 29, 2015, in the journal Nature, the researchers compared thousands of human disease-causing mutations with the analogous sequences of some 100 animal species. They discovered non-human genomes carrying mutations that cause severe disease in humans, yet were benign in the animals.
Although generally in ...
The brown marmorated stink bug has a bad reputation. And for good reason: every summer, this pest attacks crops and invades homes, causing both sizable economic losses and a messy, smelly nuisance--especially in the eastern United States. A new study by entomologists at the University of Maryland shows that these pests, known simply as stink bugs, have a strong preference for ripe fruit. Moreover, stink bugs track their favorite fruits throughout the growing season in an effort to maximize their access to food.
The study, published online June 25, 2015 in the Journal ...
PHILADELPHIA -- Since their discovery in the 1950s, transfer RNAs (tRNAs) have been best known for their role in helping the cell make proteins from messenger RNA templates. However, recent studies have led to a previously-unsuspected concept that tRNAs are not always the end product; namely, they further serve as a source of small RNAs. Now researchers have discovered a new species of tRNA-derived small RNAs that are produced only in hormonally-driven breast and prostate cancers, and which contribute to cell proliferation. The results will be published online the week ...
The warm temperature on a summer's day is often a time for relaxing, but researchers from the University of Leicester have suggested that a 'thermosensory' gene could be responsible for changes in behaviour in different climates.
The researchers from the University of Leicester's Department of Genetics have explored how the biological clock can be affected by the environment by examining the fruitfly Drosophila melanogaster, which shows 24 hour biological cycles and is used as a model organism for studies into human rhythms.
Like many humans, the fly has a 'siesta' ...
It's been difficult to explain patterns of toxic mercury in some parts of the world, such as why there's so much of the toxin deposited into ecosystems from the air in the southeastern United States, even upwind of usual sources.
A new analysis led by researchers at the University of Colorado Boulder shows that one key to understanding mercury's strange behavior may be the unexpected reactivity of naturally occurring halogen compounds from the ocean.
"Atmospheric chemistry involving bromine and iodine is turning out to be much more vigorous than we expected," said ...
